Cracker Barrel Repays $150M Debt, Dismisses GLP-1 Sales Concerns After Year of Monitoring
CBRL sits 58% above its 52-week low of $24.85 on elevated volume (2.8× avg).
Summary
Cracker Barrel announced it will repay $149.9 million in convertible notes maturing this month, utilizing its available credit facility. Crucially, the company confirmed it has seen no measurable impact on sales from GLP-1 weight-loss drugs after a year of monitoring, alleviating a major industry concern. Management also halted its larger remodel program due to customer backlash, shifting to smaller upgrades and reassessing the strategy in 2027. This update provides key financial and strategic context following yesterday's strong Q3 earnings beat and raised guidance.
At the time of this announcement, CBRL was trading at $39.34 on NASDAQ in the Trade & Services sector, with a market capitalization of approximately $811.3M. The 52-week trading range was $24.85 to $71.93. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Wiseek News.